E-LIB Suche - Ergebnisse für: Ostaszewski, Krzysztof

1

Efficacy of neoadjuvant followed by adjuvant therapy in mar..:

Czarnecka, Anna ; Ostaszewski, Krzysztof ; Blonski, Piotr...
European Journal of Surgical Oncology. 50 (2024) 2 - p. 107398 , 2024

Link: https://doi.org/10.1016/..

2

Long‐term efficacy of neoadjuvant–adjuvant targeted therapy..:

Czarnecka, Anna M. ; Ostaszewski, Krzysztof ; Błoński, Piotr J....
Cancer. , 2024

Link: https://doi.org/10.1002/..

3

Molecular and Clinicopathological Biomarkers in the Neoadju..:

Błoński, Piotr J. ; Czarnecka, Anna M. ; Ostaszewski, Krzysztof..
Biomedicines. 12 (2024) 3 - p. 669 , 2024

Link: https://doi.org/10.3390/..

4

Preoperative-postoperative immunotherapy as treatment of bo..:

Czarnecka, Anna M. ; Ostaszewski, Krzysztof ; Błoński, Piotr...
European Journal of Surgical Oncology. 50 (2024) 7 - p. 108382 , 2024

Link: https://doi.org/10.1016/..

5

Pricing reinsurance and determining optimal retention based..:

Mao, Hong ; Ostaszewski, Krzysztof
European Journal of Management and Business Economics. 32 (2023) 4 - p. 395-416 , 2023

Link: https://doi.org/10.1108/..

6

Critical condition for deposit insurance to partially or fu..:

Mao, Hong ; Ostaszewski, Krzysztof ; Wang, Jin
Journal of Economic Analysis. 2 (2023) 4 - p. , 2023

Link: https://doi.org/10.58567..

7

Development and validation of the Substance Use Protective ..:

Greń, Jakub ; Richards, Dylan K. ; Pearson, Matthew R..
International Journal of Drug Policy. , 2023

Link: https://doi.org/10.1016/..

8

Long Term Results and Prognostic Biomarkers for Anti-PD1 Im..:

Rogala, Paweł ; Czarnecka, Anna M. ; Cybulska-Stopa, Bożena...
Cancers. 14 (2022) 9 - p. 2123 , 2022

Link: https://doi.org/10.3390/..

9

Actuarial Credibility Approach in Adjusting Initial Cost Es..:

Rokicki, Bartlomiej ; Ostaszewski, Krzysztof
Sustainability. 14 (2022) 20 - p. 13371 , 2022

Link: https://doi.org/10.3390/..

10

Equivalent Risk Indicators: VaR, TCE, and Beyond:

Faroni, Silvia ; Le Courtois, Olivier ; Ostaszewski, Krzysztof
Risks. 10 (2022) 8 - p. 142 , 2022

Link: https://doi.org/10.3390/..

11

Efficacy of neoadjuvant therapy of stage IIIB-D or IV melan..:

Rutkowski, Piotr ; Ostaszewski, Krzysztof ; Borkowska, Aneta...
European Journal of Surgical Oncology. 48 (2022) 2 - p. e149 , 2022

Link: https://doi.org/10.1016/..

12

Risk and protective factors associated with internalizing a..:

Bobrowski, Krzysztof ; Ostaszewski, Krzysztof
Psychiatria Polska. 56 (2022) 5 - p. 1033-1048 , 2022

Link: https://doi.org/10.12740..

13

Long-Term Outcomes of Targeted Therapy after First-Line Imm..:

Rogala, Paweł ; Czarnecka, Anna M. ; Cybulska-Stopa, Bożena...
Journal of Clinical Medicine. 11 (2022) 8 - p. 2239 , 2022

Link: https://doi.org/10.3390/..

14

Efficacy of Neoadjuvant Targeted Therapy for Borderline Res..:

Czarnecka, Anna M. ; Ostaszewski, Krzysztof ; Borkowska, Aneta...
Cancers. 14 (2021) 1 - p. 110 , 2021

Link: https://doi.org/10.3390/..

15

Optimal Claim Settlement Strategies under Constraint of Cap..:

Mao, Hong ; Ostaszewski, Krzysztof
Mathematics. 9 (2021) 24 - p. 3284 , 2021

Link: https://doi.org/10.3390/..